The Metals Company Announces First Quarter 2024 Corporate Update Conference Call for Monday, May 13, 2024
May 06, 2024 16:30 ET
|
The Metals Company
The Metals Company Announces First Quarter 2024 Corporate Update Conference Call for Monday, May 13, 2024
Monthly information on share capital and company voting rights
May 06, 2024 16:30 ET
|
Cellectis Inc.
(Article 223-16 of General Regulation of the French financial markets authority) PARIS, May 06, 2024 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number...
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
May 06, 2024 16:30 ET
|
Cellectis Inc.
(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 06 mai 2024 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 DateNombre total...
Safe Harbor Financial to Report First Quarter 2024 Financial Results on Monday, May 13, 2024
May 06, 2024 16:30 ET
|
Safe Harbor Financial Services, Inc.
Safe Harbor Financial to Report First Quarter 2024 Financial Results on Monday, May 13, 2024
Immuneering Recognizes Melanoma Awareness Month
May 06, 2024 16:30 ET
|
Immuneering Corporation
Immuneering Recognizes Melanoma Awareness Month
Day One Reports First Quarter 2024 Financial Results and Corporate Progress
May 06, 2024 16:30 ET
|
Day One Biopharmaceuticals, Inc.
OJEMDA™ (tovorafenib) launch underway following U.S. FDA accelerated approval for relapsed or refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG) First prescriptions received in the U.S. ...
Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024
May 06, 2024 16:30 ET
|
Aptose Biosciences, Inc.
Aptose to Report First Quarter 2024 Financial Results and
Provide Clinical Strategy Update on Tuesday, May 14, 2024
OptimizeRx to Participate in Upcoming Investor Conferences
May 06, 2024 16:30 ET
|
OptimizeRx Corporation
WALTHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and...
DZS to Acquire Subscriber Access Technology Leader NetComm
May 06, 2024 16:30 ET
|
DZS
NetComm’s Subscriber Access portfolio to enhance and accelerate DZS broadband networking and cloud software portfolio, and add marquee customers.
T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity
May 06, 2024 16:29 ET
|
T2 Biosystems, Inc.
Filed Pursuant to Rule 433Issuer Free Writing Prospectus dated May 6, 2024Relating to Preliminary Prospectus dated May 6, 2024Registration No. 333-278866 LEXINGTON, Mass., May 06, 2024 (GLOBE...